Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension

Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and he...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Caio J.C.S., da Silva, Taysa A.F., Alves Jr, Jose L., Jardim, Carlos V.P., de Souza, Rogerio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829527/
https://www.ncbi.nlm.nih.gov/pubmed/33532056
http://dx.doi.org/10.1177/2045894020981350
Descripción
Sumario:Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and hemodynamical benefits of inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension.

Ejemplares similares